Search bioRxiv⌕ Search

Biology subjects

Goonetilleke, S.

Publications and source records attributed to Goonetilleke, S..

2 recordsLinked to original sources

Genomic and pedigree-based approaches to predict parental breeding values for nut and kernel traits in almond (Prunus dulcis Mill. D. A. Webb)

The self-incompatibility, perennial growth habit, large tree size, and long juvenility present challenges in applying traditional breeding approaches in almond (Prunus dulcis Mill. D. A. Webb). Moreover, nut and kernel traits in almond are mainly controlled by a large number of small-effect quantitative trait loci (QTLs) and improving complex traits through conventional breeding approaches is slow and often inefficient. Genome-wide selection represents a promising strategy to enhance the efficiency of cultivar identification and selection of superior parents in almond breeding programs by estimating the breeding values (BVs) at early maturity. The main aim of this study was to implement genomic (GBLUP) and pedigree-based (ABLUP) prediction approaches to estimate BVs to identify the superior parental candidates for improving nut and kernel traits in almond. Here, we estimated BVs for nine traits that are commonly used in the primary evaluation stage of the almond breeding using genomic data from 61 parents and phenotypic data of 15,281 progeny derived from 205 unique families. Breeding values obtained from both approaches showed a strong correlation (r [≥] 0.94) for all traits except shell seal (r = 0.87). The population structure analysis conducted using high-quality 90K single nucleotide polymorphisms (SNPs) indicated clear separation of the Californian, European and some old Australian almond cultivars, with considerable admixture across some cultivars. Following further validation, both prediction approaches could be useful in early identification of superior candidates. The slightly higher breeding values obtained using the GBLUP compared to the ABLUP approach suggest that accounting for within-family variations and realised genomic relationships can enhance prediction accuracy, reliability, and overall genomic prediction performance in almond.

genetics↗

Bacteriophage in combination with ciprofloxacin against Pseudomonas aeruginosa infections in diabetic foot ulcer patients

BackgroundIn diabetic foot ulcer (DFU) patients, Pseudomonas aeruginosa (P. aeruginosa) infections are linked to poor wound healing. The ineffectiveness of antibiotics against these infections promotes the emergence of multidrug-resistant (MDR) strains. Bacteriophage (phage) therapy has recently gained popularity as an alternative to antibiotics. MethodologyBacterial and viral swabs and tissue were obtained from DFU infections (DFI). Bacteria were cultured followed by MALDI-TOF MS for identification. 16S rRNA long-read sequencing was used to identify the microbiota. Bacteriophages were isolated and underwent transmission electron microscopy, genomic sequencing, and stability testing. The antimicrobial activity of phages alone and in combination with ciprofloxacin against P. aeruginosa planktonic cells and biofilm grown in vitro and in ex vivo tissue was tested by measuring the optical density (OD), crystal violet assays and live/dead staining with visualisation using confocal scanning laser microscopy respectively. ResultsA total of 34 DFI patients were recruited from which microbiota were analysed for 25 patients. P. aeruginosa was the most prevalent pathogen cultured and was one of the top 6 most prevalent and abundant species in the microbiota analysis. Phage APTC-PA18 was isolated from DFIs, belonged to the myoviridae family and was strictly lytic. PA18 was stable between 4 and 70 degrees Celsius and between pH 3 and 11. Seven of eight P. aeruginosa clinical isolates were sensitive to APTC-PA18, and when APTC-PA18 was combined with ciprofloxacin against planktonic and biofilm of P. aeruginosa, synergistic effects were observed in vitro and in DFI tissue samples. ConclusionPhage APTC-PA18, when combined with ciprofloxacin, has the ability to kill P. aeruginosa clinical isolates both in vitro and ex vivo and is a promising treatment option for P. aeruginosa infections in DFUs.

microbiology↗